Maguinda, Flora Mae C.
HRN: 09-78-09 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2023
DOXYCYCLINE 100MG (CAP)
08/19/2023
09/02/2023
PO
100mg
BID X 14 Days
Ruptured Ampullary Pregnancy, Right
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes